<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">860387</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2022.860387</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Disease-Related Protein Variants of the Highly Conserved Enzyme PAPSS2 Show Marginal Stability and Aggregation in Cells</article-title>
<alt-title alt-title-type="left-running-head">Brylski et al.</alt-title>
<alt-title alt-title-type="right-running-head">Disease-Related PAPSS2 Protein Variants</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Brylski</surname>
<given-names>Oliver</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/707753/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shrestha</surname>
<given-names>Puja</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1498086/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>House</surname>
<given-names>Philip J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gnutt</surname>
<given-names>Patricia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mueller</surname>
<given-names>Jonathan Wolf</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/341054/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ebbinghaus</surname>
<given-names>Simon</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/582102/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Physical and Theoretical Chemistry</institution>, <institution>TU Braunschweig</institution>, <addr-line>Braunschweig</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Physical Chemistry II</institution>, <institution>Ruhr University</institution>, <addr-line>Bochum</addr-line>, <country>Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Metabolism and Systems Research (IMSR)</institution>, <institution>University of Birmingham</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Centre for Endocrinology</institution>, <institution>Diabetes and Metabolism (CEDAM)</institution>, <institution>Birmingham Health Partners</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/217880/overview">Giuseppe Calamita</ext-link>, University of Bari Aldo Moro, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/930663/overview">Annarita Di Mise</ext-link>, University of Bari Aldo Moro, Italy</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1032640/overview">Antonio Rossi</ext-link>, University of Pavia, Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jonathan Wolf Mueller, <email>j.w.mueller@bham.ac.uk</email>; Simon Ebbinghaus, <email>s.ebbinghaus@tu-braunschweig.de</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>860387</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>02</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Brylski, Shrestha, House, Gnutt, Mueller and Ebbinghaus.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Brylski, Shrestha, House, Gnutt, Mueller and Ebbinghaus</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Cellular sulfation pathways rely on the activated sulfate 3&#x2032;-phosphoadenosine-5&#x2032;-phosphosulfate (PAPS). In humans, PAPS is exclusively provided by the two PAPS synthases PAPSS1 and PAPSS2. Mutations found in the PAPSS2 gene result in severe disease states such as bone dysplasia, androgen excess and polycystic ovary syndrome. The APS kinase domain of PAPSS2 catalyzes the rate-limiting step in PAPS biosynthesis. In this study, we show that clinically described disease mutations located in the naturally fragile APS kinase domain are associated either with its destabilization and aggregation or its deactivation. Our findings provide novel insights into possible molecular mechanisms that could give rise to disease phenotypes associated with sulfation pathway genes.</p>
</abstract>
<kwd-group>
<kwd>PAPS synthase</kwd>
<kwd>sulfation pathways</kwd>
<kwd>in-cell spectroscopy</kwd>
<kwd>protein folding</kwd>
<kwd>stability and aggregation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Sulfation is a highly important biological process where a sulfate moiety from the activated sulfate donor 3&#x2032;-phosphoadenosine-5&#x2032;-phosphosulfate (PAPS) is transferred onto acceptor molecules. Adding the negatively charged sulfate group to a hydroxyl-group induces significant changes in the chemical properties of the acceptor molecule with a major impact on their function. It is the sheer variety of sulfated metabolites that makes sulfation impactful on numerous biological systems. Sulfotransferases use activated sulfate to modify proteins, glycans and other biomolecules like steroid hormones (<xref ref-type="bibr" rid="B27">Klassen and Boles, 1997</xref>; <xref ref-type="bibr" rid="B44">Strott, 2002</xref>; <xref ref-type="bibr" rid="B31">Mueller et al., 2015</xref>).</p>
<p>Active PAPS synthase enzymes generate active sulfate in the form of PAPS. In humans, there are two isoforms PAPSS1 and PAPSS2 (<xref ref-type="bibr" rid="B46">van den Boom et al., 2012</xref>). Nevertheless, disease-related protein variants have been exclusively reported for PAPSS2.</p>
<p>In a variety of human genetics studies, a total of 65 individuals with various inactivating alleles of the human PAPSS2 gene have been described (<xref ref-type="bibr" rid="B1">Ahmad et al., 1998</xref>; <xref ref-type="bibr" rid="B23">Haque et al., 1998</xref>; <xref ref-type="bibr" rid="B34">Noordam et al., 2009</xref>; <xref ref-type="bibr" rid="B30">Miyake et al., 2012</xref>; <xref ref-type="bibr" rid="B25">Iida et al., 2013</xref>; <xref ref-type="bibr" rid="B45">T&#xfc;ys&#xfc;z et al., 2013</xref>; <xref ref-type="bibr" rid="B35">Oostdijk et al., 2015</xref>; <xref ref-type="bibr" rid="B22">Handa et al., 2016</xref>; <xref ref-type="bibr" rid="B4">Bownass et al., 2019</xref>; <xref ref-type="bibr" rid="B13">Eltan et al., 2019</xref>; <xref ref-type="bibr" rid="B37">Perez-Garcia et al., 2021</xref>). These have been analyzed and summarized recently (<xref ref-type="bibr" rid="B2">Baranowski et al., 2018</xref>; <xref ref-type="bibr" rid="B5">Brylski et al., 2019</xref>; <xref ref-type="bibr" rid="B36">Paganini et al., 2020</xref>). An additional PAPSS2 variant is known for brachymorphic mice (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>).</p>
<p>Recently, several studies investigated the essential steps in sulfation pathways, whose malfunction is correlated with disease symptoms (<xref ref-type="bibr" rid="B31">Mueller et al., 2015</xref>; <xref ref-type="bibr" rid="B14">Foster and Mueller, 2018</xref>). Among these symptoms are bone and cartilage dysplasia (<xref ref-type="bibr" rid="B35">Oostdijk et al., 2015</xref>), as well as androgen excess and polycystic ovary syndrome (PCOS) (<xref ref-type="bibr" rid="B34">Noordam et al., 2009</xref>; <xref ref-type="bibr" rid="B35">Oostdijk et al., 2015</xref>), all caused by point-mutations in the <italic>PAPSS2</italic> gene encoding for the PAPS synthase 2 enzyme. These point mutations diminish the enzyme activity and they are mainly located within the kinase domain of PAPSS2 (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>; <xref ref-type="bibr" rid="B34">Noordam et al., 2009</xref>; <xref ref-type="bibr" rid="B25">Iida et al., 2013</xref>).</p>
<p>It is evident that PAPSS2 plays a vital role in skeletal development as well as steroid hormones regulation (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>; <xref ref-type="bibr" rid="B34">Noordam et al., 2009</xref>; <xref ref-type="bibr" rid="B25">Iida et al., 2013</xref>). Kurima and coworkers linked the mutation G78R within the nucleotide kinase domain of the PAPSS2 isoform, with the bone phenotype seen in the brachymorphic mouse (<italic>bm</italic>) (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>). G78R is located in the adenosine-5&#x2032;-phosphosulfate (APS) kinase domain, close to the ligand-binding site. The mutation causes catalytic inactivation and hence lowered intracellular PAPS availability. As a consequence, <italic>bm</italic> mice show reduced postnatal growth that was ascribed to under-sulfation of the extracellular matrix; they also show abnormal hepatic detoxification and prolonged bleeding times (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>). One of the most prominent roles of sulfation is the modification of glycosaminoglycans (GAGs) by Golgi-residing carbohydrate sulfotransferases (<xref ref-type="bibr" rid="B17">Gesteira et al., 2021</xref>). Sulfated GAGs play a vital role in cell signaling to regulate many biochemical processes like cell growth and proliferation, promotion of cell adhesion, anticoagulation and wound repair (<xref ref-type="bibr" rid="B39">Raman et al., 2005</xref>; <xref ref-type="bibr" rid="B38">Prydz, 2015</xref>). In brachymorphic cartilage, GAGs are found at normal level but significantly under-sulfated, affecting the formation of connective tissue, such as, cartilage (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>; <xref ref-type="bibr" rid="B8">Cho et al., 2004</xref>).</p>
<p>More recently, Noordam and coworkers reported a case study of a girl with premature pubarche, hyperandrogenic anovulation, very low level of dehydro-epiandrosterone sulfate (DHEAS) and high level of androgen. The steroid sulfation defect of this patient was associated with a T48R mutation found in the APS kinase domain. Due to this mutation, PAPS synthesis is affected, leading to incompetent DHEA inactivation, with the latter resulting in increased levels of androgens causing PCOS-like phenotypes (<xref ref-type="bibr" rid="B34">Noordam et al., 2009</xref>). In 2013, Iida and coworkers reported more PAPSS2 mutations (C43Y, L76Q, E183K, V540D) out of which three, C43Y, L76Q and E183K, were found in the APS kinase domain. C43Y and L76Q cause loss of function leading to brachyolmia and abnormal androgen metabolism (<xref ref-type="bibr" rid="B25">Iida et al., 2013</xref>).</p>
<p>Eukaryotic cells express another PAPS synthase gene, PAPSS1, that shares 78% identity at the level of amino acid sequence (<xref ref-type="bibr" rid="B46">van den Boom et al., 2012</xref>). However, this protein isoform cannot compensate for the loss of the other (<xref ref-type="bibr" rid="B32">Mueller et al., 2018</xref>). This lack of compensation raises the question of whether the two isoforms impact differently on subsets of sulfation pathways. Subcellular localization sequences (<xref ref-type="bibr" rid="B41">Schr&#xf6;der et al., 2012</xref>) were identified in both PAPS synthases and dimer formation (<xref ref-type="bibr" rid="B42">Sekulic et al., 2007</xref>; <xref ref-type="bibr" rid="B21">Grum et al., 2010</xref>; <xref ref-type="bibr" rid="B5">Brylski et al., 2019</xref>) was observed, both features proposed to be crucial for proper localization and activity of the enzyme. In addition to these physiological aspects, <italic>in vitro</italic> biophysical studies focused on the stability of PAPS synthases revealed that isoforms of this enzyme are only marginally stable as recombinant proteins (<xref ref-type="bibr" rid="B46">van den Boom et al., 2012</xref>). However, PAPS synthase proteins can be stabilized by preferential binding of their substrates to the APS kinase domain, namely PAPS, adenosine diphosphate (ADP) and APS (<xref ref-type="bibr" rid="B46">van den Boom et al., 2012</xref>; <xref ref-type="bibr" rid="B33">Mueller and Shafqat, 2013</xref>).</p>
<p>Using a recently developed folding sensor of the APS kinase domain of the human PAPS synthase PAPSS2 (<xref ref-type="bibr" rid="B6">Brylski et al., 2021</xref>), we investigate how clinically reported single-point-mutations change the in-cell stability of the APS kinase domain and if destabilization could lead to aggregation and thus loss of metabolic activity.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Construction of PAPSS2 and APSK37 Variants</title>
<p>The pEGFP-C1-PAPSS2 plasmid encoding human full-length PAPSS2b&#xa0;C-terminally fused to an EGFP fluorescent protein (<xref ref-type="bibr" rid="B41">Schr&#xf6;der et al., 2012</xref>), was used for DpnI-based site-directed mutagenesis and subsequently for cell counting experiments. To generate the APSK37 sensor, the APS kinase domain of PAPSS2 was PCR-subcloned into a modified pDream2.1 vector with an N-terminal AcGFP1 and a C-terminal mCherry (<xref ref-type="bibr" rid="B12">Ebbinghaus et al., 2010</xref>). The APSK enzyme was truncated between the two isoleucine residues I220 and I221, within the flexible linker that connects the kinase and the sulfurylase domains (<xref ref-type="bibr" rid="B24">Harjes et al., 2005</xref>). Furthermore, the flexible and disordered N-terminal region, which is known to assist in the dimerization of the protein (<xref ref-type="bibr" rid="B42">Sekulic et al., 2007</xref>; <xref ref-type="bibr" rid="B21">Grum et al., 2010</xref>), was truncated by 37 amino acids (&#x394;37). Further, DpnI-based site-directed mutagenesis was used to introduce different disease related point mutations (G78R, L76Q, C43Y and T48R). All constructs were verified by Sanger DNA sequencing.</p>
</sec>
<sec id="s2-2">
<title>Cell Culture and Plasmid Transfection</title>
<p>HeLa cells were grown at 5% CO<sub>2</sub> at 37&#xb0;C in DMEM supplemented with 10% FBS, 100&#xa0;U/ml penicillin and 0.1&#xa0;mg/ml streptomycin. Cells were passaged at a 1:4 or 1:6 ratios at 80&#x2013;90% confluence, using trypsin digestion. For transfection, cells were seeded in six-well plates (Sarstedt). Using Lipofectamine 3000 (Thermo Fisher), cells were transfected according to the manufacturers protocol. Concisely, a mixture of 125&#xa0;&#xb5;l Opti-MEM (Thermo Fisher) with 2&#xa0;&#xb5;g of the respective plasmid DNA and 4&#xa0;&#xb5;l P3000 reagents was prepared. After 5&#xa0;min of incubation, the mixture was transferred to another solution containing 125&#xa0;&#xb5;l Opti-MEM supplemented with 4&#xa0;&#xb5;l Lipofectamine3000 reagent. Cells were incubated for 6&#xa0;h after the addition of transfection mixture to the cellular growth medium at 5% CO<sub>2</sub>, 37&#xb0;C. The cells were passaged using trypsin digestion and seeded in 35&#xa0;mm glass bottom dishes (Fluorodish, World Precision Instruments). Cells were grown for 2&#xa0;days at standard cell culture conditions before imaging.</p>
</sec>
<sec id="s2-3">
<title>Sample Preparation</title>
<p>Fast Relaxation Imaging (FReI) was performed with transfected cells grown on 35&#xa0;mm glass bottom dishes (Fluorodish, World Precision Instruments). Cells were washed with Dulbecco&#x2019;s Phosphate Buffered Saline (DPBS) (Sigma-Aldrich) after removing the growth medium. 30&#xa0;&#xb5;L Leibovitz&#x2019;s L15 medium supplemented with 30% FBS were sealed between a glass cover slip (Menzel &#x23;1.0) with a 120&#xa0;&#xb5;m thick imaging spacer (Sigma-Aldrich) and a glass bottom dish with cells.</p>
</sec>
<sec id="s2-4">
<title>Fast Relaxation Imaging Measurements</title>
<p>FReI is a combination of wide field fluorescence microscopy with millisecond temperature jumps induced by an IR diode laser (m2k-Laser, 2200&#xa0;nm). The technique was previously described (<xref ref-type="bibr" rid="B12">Ebbinghaus et al., 2010</xref>; <xref ref-type="bibr" rid="B19">Gnutt et al., 2019a</xref>). Shortly, fluorescent light was split by a dichroic beam splitter into donor and acceptor signal that was recorded using CCD cameras while the sample is rapidly heated by an IR laser. The temperature sensitive dye Rhodamine B (Sigma Aldrich) was used for the calibration of temperature jumps (<xref ref-type="bibr" rid="B48">V&#xf6;pel et al., 2015</xref>; <xref ref-type="bibr" rid="B16">Gao et al., 2016</xref>; <xref ref-type="bibr" rid="B7">B&#xfc;ning et al., 2017</xref>). The heat profile used in this study showed an average temperature increase of 2.2&#xb0;C per jump at intervals of 50&#xa0;s, covering a range from 23.0 to 58.2&#xb0;C in 16 steps. Image acquisition was performed at one frame per second (fps) with LED exposure times typically between 50 and 200&#xa0;ns. Data was recorded using AxioVision software and the images were processed and analyzed using ImageJ (National Institute of Health, United States) and further evaluated using self-written MatLab (Mathworks) codes and GraphPad Prism 6 (GraphPad).</p>
<p>For data analysis, fluorescence intensities were averaged throughout the cytoplasmic region for each channel individually (<xref ref-type="bibr" rid="B11">Dhar et al., 2011</xref>). Further, background subtraction was performed for the individual channels and the ratio of the donor and acceptor channel (D/A) calculated. The changes of D/A ratio upon temperature jump yield information about the associated conformational change. An increase in D/A refers a decrease in FRET that may be attributed to protein unfolding. To analyze the kinetics of protein unfolding, the individual channel intensities were used as D-&#x3b1;A according to (<xref ref-type="bibr" rid="B11">Dhar et al., 2011</xref>). To determine the melting point (T<sub>M</sub>) of the protein, the thermodynamic model introduced as <italic>Better thermodynamics from kinetics</italic> (<xref ref-type="bibr" rid="B18">Girdhar et al., 2011</xref>) was used:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>D</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>&#x3b1;</mml:mi>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>&#x3b4;</mml:mi>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi mathvariant="normal">&#x394;</mml:mi>
<mml:mi>T</mml:mi>
<mml:mo>&#x22c5;</mml:mo>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi mathvariant="normal">&#x394;</mml:mi>
<mml:mi>T</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x22c5;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mi>m</mml:mi>
<mml:mi>A</mml:mi>
</mml:msub>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x22c5;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mtext>exp</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>&#x3b4;</mml:mi>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">&#x394;</mml:mi>
<mml:mi>T</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x22c5;</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi mathvariant="normal">&#x394;</mml:mi>
<mml:mi>T</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mtext>exp</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>&#x3b4;</mml:mi>
<mml:msub>
<mml:mi>g</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">&#x394;</mml:mi>
<mml:mi>T</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x22c5;</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi mathvariant="normal">&#x394;</mml:mi>
<mml:mi>T</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>Where, &#x2202;g1 is pre-factor of the linear Taylor approximation of the two-state populations. &#x394;T is the amplitude of the temperature jump (set to 2.2&#xb0;C) and A<sub>0</sub> and m<sub>A</sub> are fitting parameters of the underlying baseline (with m<sub>A</sub> set to 0).</p>
</sec>
<sec id="s2-5">
<title>HEK293 Cell Culture and Wide Field Microscopy</title>
<p>HEK293 cells were cultured in DMEM with high glucose (Gibco, United Kingdom), supplemented with 10% fetal FBS and penicillin/streptomycin at 1%. Cells were passaged at 80&#x2013;90% confluence, using trypsin digestion. Regular checks ensured that all cells were mycoplasma-free. Cells were seeded 1:8 or 1:10 in culture flasks or maintaining stocks or at 200,000 cells per well into six-well plates with microscopic slides in them. Transfection of these HEK293 cells 24&#xa0;h after seeding on cover slips was performed using the XtremeGENE HP DNA transfection reagent (Roche, United Kingdom), according to manufacturer&#x2019;s instructions. Cells were left growing for 24 or 48&#xa0;h, then washed with ice-cold PBS and incubated with ice-cold methanol, followed by three further washing steps using PBS. Finally, cover slips with cells were mounted on microscopic slides, using fluorescence mounting media, and fixed with nail varnish. The slides were anonymized to enable blind, non-biased analysis. The slides were then viewed under a wide-field fluorescent microscope and scored at least three different sections using a &#xd7;20 objective. Cells were imaged with a &#xd7;20 objective. The number of speckles per cell was scored in large numbers of cells, in a blinded fashion. As a control, fluorescence intensity was ranked as well (low/medium/high). No correlation was found between fluorescence intensity and number of speckles, suggesting that protein over-expression levels were not linked to the observed patterns of speckles. Significant changes of population of non-speckled cells have been determined using two-way ANOVA with a <italic>post-hoc</italic> Holm-Sidak&#x2019;s test correcting for multiple comparisons.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Mutations in APSK37 Reveal Distinct Folding Stabilities</title>
<p>We analyzed the effect of disease-related mutations on the folding stability and aggregation of the APS kinase domain of the bifunctional PAPSS2 protein, using our recently established APSK folding sensor (APSK37) (<xref ref-type="bibr" rid="B6">Brylski et al., 2021</xref>). The sensor reports intramolecular FRET between the N-terminal AcGFP1 and the C-terminal mCherry fusion proteins (<italic>see</italic> Materials and Methods for details).</p>
<p>We analyzed PAPS synthase disease point mutations located in the APS kinase domain to understand whether the phenotypes seen clinically correlate with misfolded, destabilized or inactive protein. Therefore, we created the variants G78R, L76Q, T48R and C43Y within APSK37 (<xref ref-type="bibr" rid="B35">Oostdijk et al., 2015</xref>), expressed them in HeLa cells and studied their in-cell protein stability in comparison to the wt protein using Fast Relaxation Imaging (FReI). In FReI, a rapid perturbation of temperature is applied by absorption of infrared light (IR) by the sample (<xref ref-type="bibr" rid="B12">Ebbinghaus et al., 2010</xref>; <xref ref-type="bibr" rid="B47">V&#xf6;pel et al., 2017</xref>; <xref ref-type="bibr" rid="B20">Gnutt et al., 2019b</xref>) (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>). Dual-color imaging allows to measure changes in donor-to-acceptor intensity ratio (D/A) (<xref ref-type="fig" rid="F1">Figure 1C</xref>) that display unfolding kinetics and thermodynamics of the protein in the cell (<italic>see</italic> Materials and Methods for details) (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>In-cell thermal unfolding of APSK37 wt using Fast Relaxation Imaging. <bold>(A)</bold> Schematic representation of the Fast Relaxation Imaging setup. <bold>(B)</bold> Induced temperature profile calculated by the calibration procedure published in <xref ref-type="bibr" rid="B7">B&#xfc;ning et al., 2017</xref>. <bold>(C)</bold> Change in fluorescence according to the temperature profile in B of the APSK37 AcGFP1 FRET donor (D) and the mCherry FRET acceptor <bold>(A)</bold>. <bold>(D)</bold> D/A ratio calculated from the intensity data in <bold>(C)</bold>. The thermal unfolding region is shaded in blue and the calculated T<sub>M</sub> is displayed by a dash blue line. <bold>(E)</bold> Crystal structure of the APSK domain of PAPSS2 (PDB:2AX4). Studied mutations are shown as red spheres. ADP/ATP (green) and APS/PAPS (yellow) binding sites are indicated by the substrates surface representation.</p>
</caption>
<graphic xlink:href="fmolb-09-860387-g001.tif"/>
</fig>
<p>A structural analysis of the surface exposure of the disease-related mutants revealed that C43Y, T48R and L76Q are deeply buried in the protein core (solvent accessible surface area (SASA) &#x2264; 1&#xa0;&#xc5;<sup>2</sup>) compared to G78R (<xref ref-type="bibr" rid="B26">Kabsch and Sander, 1983</xref>; <xref ref-type="bibr" rid="B5">Brylski et al., 2019</xref>); all of them located in close proximity in the central beta-sheet of the APSK (<xref ref-type="fig" rid="F1">Figure 1E</xref>).</p>
<p>For APSK37 wt, we observed an increase of the normalized D/A ratio upon IR-laser heating and decrease after returning to the starting temperature (<xref ref-type="fig" rid="F2">Figure 2A</xref>). This behavior is also evident for G78R mutant (<xref ref-type="fig" rid="F2">Figure 2B</xref>), which exhibits an apparent two-state folding behavior as the respective unfolding kinetics can be fitted by a single exponential function. Plotting and fitting the respective amplitudes against temperature (<xref ref-type="fig" rid="F2">Figures 2C,D</xref>) allowed the determination of a T<sub>M</sub> &#x3d; 46.1 &#xb1; 2.1&#xb0;C which is similar to wt (48.0 &#xb1; 1.7&#xb0;C) (<xref ref-type="fig" rid="F2">Figure 2E</xref>). Additionally, no significant differences were found with respect to the modified standard state free energies of folding &#x394;G<sub>f</sub>
<sup>0&#x2019;</sup>, suggesting that this mutation does not affect the stability of the protein (<xref ref-type="fig" rid="F2">Figure 2F</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Thermal unfolding curve APSK37 wt and mutants (G78R). <bold>(A)</bold> Exemplary temperature induced thermal unfolding curves of wt (data shown from (<xref ref-type="bibr" rid="B6">Brylski et al., 2021</xref>)). <bold>(B)</bold> Exemplary temperature induced thermal unfolding curves of G78R. <bold>(C)</bold> Exponential unfolding curves of single temperature jumps from panel <bold>(B)</bold> showing the relaxations kinetics at the respective temperatures. <bold>(D)</bold> Kinetic amplitudes as a function of temperature to determine the T<sub>m</sub> (dashed line). <bold>(E)</bold> Thermal stability comparison of the mutant G78R with APSK37 wt: Melting points of APSK37 (green) and melting point of G78R (blue) derived from FReI measurrement showing average &#xb1; s.d. <bold>(F)</bold> Folding free energy &#x2206;G<sub>f</sub>
<sup>0&#x2019;</sup> for both APSK37 wt and G78R mutant with mean &#xb1; s.d. There are no statistically significant differences between wt and G78R. Significance were tested <italic>via</italic> one-way ANOVA with a <italic>post-hoc</italic> Holm-Sidak test correcting for multiple comparisons (no significant changes observed).</p>
</caption>
<graphic xlink:href="fmolb-09-860387-g002.tif"/>
</fig>
<p>For the mutations C43Y, T48R and L76Q, we did not detect any unfolding transitions, impeding the determination of T<sub>M</sub>. We rather observed a strong decrease in the D/A ratio (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;C</xref>) that can be attributed to an increase in FRET by intermolecular energy transfer due to self-association (<xref ref-type="bibr" rid="B12">Ebbinghaus et al., 2010</xref>; <xref ref-type="bibr" rid="B7">B&#xfc;ning et al., 2017</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Exemplary temperature-induced thermal unfolding curves of the L76Q, T48RM, and C43Y mutants are visible in <xref ref-type="fig" rid="F3">Figures 3A&#x2013;C</xref>, respectively.</p>
</caption>
<graphic xlink:href="fmolb-09-860387-g003.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Self-Association and Aggregation of C43Y, T48R and L76Q</title>
<p>We then investigated if the self-association events observed in FReI result in the formation of microscopically visible aggregates. We monitored their formation by wide-field fluorescence microscopy of EGFP-labeled full-length human PAPS synthase 2 carrying the disease mutants, expressed in HEK293 cells along with PAPSS 2 wt proteins. The cellular distribution pattern of the protein and degree of aggregate formation was scored by classifying individual cells according to the number of speckles that were visible inside each cell (<xref ref-type="fig" rid="F4">Figure 4A</xref>). <xref ref-type="fig" rid="F4">Figure 4B</xref> illustrates the cellular distribution pattern of the protein and the degree of aggregate formation for different mutants compared to PAPSS2 wt. The mutants C43Y, T48R and L76Q caused a higher number of aggregates compared to PAPSS2 wt. The level of aggregate formation of the G78R mutation is not significantly different from wt. Thus, the results show that the self-association of the C43Y, T48R and L76Q APSK37 proteins measured by FReI is in accordance with protein aggregation of the respective mutants in the full-length PAPSS2 protein. On the other hand, the G78R mutant is stable and does not lead to aggregation both in APSK37 and PAPSS2 proteins.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Expression and distribution of recombinant human PAPSS in HEK293 cells. <bold>(A)</bold> Exemplary fluorescence image of HEK293 cells showing fluorescence spots classified according to three categories. <bold>(B)</bold> Even distribution; no speckles: grade 1, 1&#x2013;3 speckles: grade 2, 4&#x2013;10 speckles: grade 3 and more than 10 speckles or large clumps: grade 4. Data is presented as average &#xb1; s.e.m. Cells were counted from four different slides (<italic>N</italic> &#x3d; 4) with <italic>n</italic> &#x3e; 200 cells in total for each protein variant. Asterisks indicate significant differences of the fraction of cells showing no speckles compared to PAPSS2 wt (&#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001). Additional statistical significance within grade 1 was found between G78R and T48R(&#x2a;&#x2a;&#x2a;) or G78R and L76Q(&#x2a;).</p>
</caption>
<graphic xlink:href="fmolb-09-860387-g004.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Generally, proteins with disease-related mutations either show a loss of catalytic function, a gain of toxic function (<xref ref-type="bibr" rid="B51">Winklhofer et al., 2008</xref>; <xref ref-type="bibr" rid="B9">De Baets et al., 2015</xref>) or a significant loss in stability of the protein leading to misfolding and aggregation (<xref ref-type="bibr" rid="B50">Waters, 2001</xref>; <xref ref-type="bibr" rid="B10">Denny et al., 2013</xref>; <xref ref-type="bibr" rid="B15">Gandhi et al., 2019</xref>). For PAPSS2, many studies have shown that disease-related gene defects cause different forms of bone and cartilage malformation (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>; <xref ref-type="bibr" rid="B25">Iida et al., 2013</xref>), as a consequence of under-sulfation of extracellular matrix. Dysregulation of steroid metabolism causing an increase in androgen activation is further associated with diseases like PCOS and premature pubarche (<xref ref-type="bibr" rid="B34">Noordam et al., 2009</xref>).</p>
<p>The results of this study show that PAPSS2 disease-related mutations cause a destabilization and aggregation of the enzyme in cellular environments for the mutants C43Y, T48R, L76Q. The G78R mutation however shows a folding stability that is comparable to wt, preventing aggregation. Regarding catalysis, Kurima and coworkers have reported that the G78R variant has very little residual APS kinase activity, but the ATP sulfurylase activity was comparable to wt (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>). Conformational changes of the APS binding site upon mutation, modifying the interaction between the ATP &#x3b3;-phosphate group, the magnesium ion and the DGDN-loop can be a potential reason for the catalytic inhibition APS kinase (<xref ref-type="bibr" rid="B29">Kurima et al., 1998</xref>). The mutation may not disrupt the native fold, however, a catalytic conversion, for example due to a loss in flexibility within the DGDN-loop, may not be possible anymore.</p>
<p>The mutations C43Y, T48R, and L76Q destabilize APSK37 and lead to aggregation of both APSK37 and full-length PAPS synthase. All three mutations reside in the central &#x3b2;-sheet region of the protein (<xref ref-type="fig" rid="F1">Figure 1E</xref>), suggesting that this is a sensitive region that maintains the native fold and prevents self-association and aggregation. Changes in the protein&#x2019;s native structure, protein-protein interactions and many other sequential and parallel events can lead to misfolded/unfolded conformations, resulting in aggregation. Protein aggregation is often linked with various pathologies, including neurodegenerative diseases, such as Alzheimer&#x2019;s, Parkinson&#x2019;s and Huntington&#x2019;s. These disease-related aggregates are generally sub-divided into loss-of-function and gain-of- toxic function effects (<xref ref-type="bibr" rid="B40">Ross and Poirier, 2004</xref>; <xref ref-type="bibr" rid="B49">Wang, 2005</xref>; <xref ref-type="bibr" rid="B43">Soto and Pritzkow, 2018</xref>). Indeed, the three above-mentioned PAPSS mutations were previously classified as &#x201c;missense mutants,&#x201d; causing its loss of function (<xref ref-type="bibr" rid="B34">Noordam et al., 2009</xref>; <xref ref-type="bibr" rid="B25">Iida et al., 2013</xref>). Missense mutations in nuclear deubiquitinase BAP1 were previously shown to induce destabilization and aggregation of this enzyme, with the latter being suggested as the main cause of its functional loss (<xref ref-type="bibr" rid="B3">Bhattacharya et al., 2016</xref>). In fact, this hypothesis is further supported by our previous studies (<xref ref-type="bibr" rid="B6">Brylski et al., 2021</xref>) using an alanine scanning mutagenesis of the substrate binding site of APSK37 in HeLa cells. The results revealed a large range of different in-cell stabilities for the single point mutations (&#x394;G<sub>f</sub>
<sup>0</sup> &#x3d; &#x2212;10.7 to &#x2b;13.8&#xa0;kJ/mol).</p>
<p>Our results suggest two distinct possible disease mechanisms, one related to misfolding and aggregation, and the other one related to inhibition of catalytic function. However, whether these processes are causal for the different pathologies needs to be elucidated in future studies.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>So far, many sulfotransferase-related mutations are known to be associated with the sulfation pathway but a lot less is reported for PAPSS. Our results report that PAPSS2 disease-related mutations cause misfolding and aggregation (L76Q, T48R, and C43Y), and inhibition of the catalytic function (G78R). Even though our study showed that the three missense mutants (L76Q, T48R and C43Y) lead to aggregation, the molecular details of this process remains to be explored, particularly putative cytotoxic effects of amyloid formation. Therapeutic approaches against the rare diseases that are associated with these mutations may thus be different, encompassing supplementation of lacking compounds (<xref ref-type="bibr" rid="B28">Klinge et al., 2018</xref>) or inhibitors to reduce aggregation (<xref ref-type="bibr" rid="B47">V&#xf6;pel et al., 2017</xref>).</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>JWM and SE, designed the study; OB, PS, PJH, and PG, acquired data. OB, PS, PJH, PG, JWM, and SE, analyzed and interpreted data. OB and JWM, drafted the work. OB, PS, JWM, and SE, revised it critically for important intellectual content. All authors approved the final version of the manuscript and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>We acknowledge funding from the Cluster of Excellence RESOLV (EXC 1069) and the Human Frontier Science Program (Research Grant RGP0022/2017). OB was supported by the Graduate School of Solvation Science (Ruhr University Bochum). JWM was supported by the European Commission Marie Curie Fellowship SUPA-HD (625451).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ul Haque</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Abbas</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Krakow</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Distinct, Autosomal Recessive Form of Spondyloepimetaphyseal Dysplasia Segregating in an Inbred Pakistani kindred</article-title>. <source>Am. J. Med. Genet.</source> <volume>78</volume>, <fpage>468</fpage>&#x2013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1096-8628(19980806)78:5&#x3c;468:aid-ajmg13&#x3e;3.0.co;2-d</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baranowski</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Arlt</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Idkowiak</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Monogenic Disorders of Adrenal Steroidogenesis</article-title>. <source>Horm. Res. Paediatr.</source> <volume>89</volume>, <fpage>292</fpage>&#x2013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1159/000488034</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hanpude</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maiti</surname>
<given-names>T. K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Cancer Associated Missense Mutations in BAP1 Catalytic Domain Induce Amyloidogenic Aggregation: A New Insight in Enzymatic Inactivation</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>18462</fpage>. <pub-id pub-id-type="doi">10.1038/srep18462</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bownass</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Abbs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Baujat</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Behzadi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Berentsen</surname>
<given-names>R. D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>PAPSS2 &#x2010;related Brachyolmia: Clinical and Radiological Phenotype in 18 New Cases</article-title>. <source>Am. J. Med. Genet.</source> <volume>179</volume>, <fpage>1884</fpage>&#x2013;<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.61282</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brylski</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ebbinghaus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Melting Down Protein Stability: PAPS Synthase 2 in Patients and in a Cellular Environment</article-title>. <source>Front. Mol. Biosci.</source> <volume>6</volume>, <fpage>31</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2019.00031</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brylski</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Shrestha</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gnutt</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gnutt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Ebbinghaus</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cellular ATP Levels Determine the Stability of a Nucleotide Kinase</article-title>. <source>Front. Mol. Biosci.</source> <volume>8</volume>, <fpage>790304</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2021.790304</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#xfc;ning</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vachharajani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Newcombe</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ormsby</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Conformational Dynamics and Self-Association of Intrinsically Disordered Huntingtin Exon 1 in Cells</article-title>. <source>Phys. Chem. Chem. Phys.</source> <volume>19</volume>, <fpage>10738</fpage>&#x2013;<lpage>10747</lpage>. <pub-id pub-id-type="doi">10.1039/C6CP08167C</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>J.-S.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Under-sulfation by PAPS Synthetase Inhibition Modulates the Expression of ECM Molecules during Chondrogenesis</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>323</volume>, <fpage>769</fpage>&#x2013;<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.08.173</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Baets</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Van Doorn</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schymkowitz</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Increased Aggregation Is More Frequently Associated to Human Disease-Associated Mutations Than to Neutral Polymorphisms</article-title>. <source>PLOS Comput. Biol.</source> <volume>11</volume>, <fpage>e1004374</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1004374</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denny</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Gavrin</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Saiah</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Recent Developments in Targeting Protein Misfolding Diseases</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>23</volume>, <fpage>1935</fpage>&#x2013;<lpage>1944</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2013.01.089</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Girdhar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gelman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ebbinghaus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gruebele</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Protein Stability and Folding Kinetics in the Nucleus and Endoplasmic Reticulum of Eucaryotic Cells</article-title>. <source>Biophysical J.</source> <volume>101</volume>, <fpage>421</fpage>&#x2013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2011.05.071</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebbinghaus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dhar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Gruebele</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Protein Folding Stability and Dynamics Imaged in a Living Cell</article-title>. <source>Nat. Methods</source> <volume>7</volume>, <fpage>319</fpage>&#x2013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1435</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eltan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yavas&#xa0;Abali</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Arslan&#xa0;Ates</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kirkgoz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaygusuz</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>T&#xfc;rky&#x131;lmaz</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Low DHEAS Concentration in a Girl Presenting with Short Stature and Premature Pubarche: A Novel PAPSS2 Gene Mutation</article-title>. <source>Horm. Res. Paediatr.</source> <volume>92</volume>, <fpage>262</fpage>&#x2013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1159/000502114</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foster</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>SULFATION PATHWAYS: Insights into Steroid Sulfation and Desulfation Pathways</article-title>. <source>J. Mol. Endocrinol.</source> <volume>61</volume>, <fpage>T271</fpage>&#x2013;<lpage>T283</lpage>. <pub-id pub-id-type="doi">10.1530/JME-18-0086</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gandhi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Antonelli</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Afridi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vatsia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Romanov</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Protein Misfolding and Aggregation in Neurodegenerative Diseases: a Review of Pathogeneses, Novel Detection Strategies, and Potential Therapeutics</article-title>. <source>Rev. Neurosci.</source> <volume>30</volume>, <fpage>339</fpage>&#x2013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1515/revneuro-2016-0035</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gnutt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Orban</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Appel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Righetti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>RNA Hairpin Folding in the Crowded Cell</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>55</volume>, <fpage>3224</fpage>&#x2013;<lpage>3228</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201510847</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gesteira</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>Marforio</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Calvaresi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Coulson-Thomas</surname>
<given-names>V. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Structural Determinants of Substrate Recognition and Catalysis by Heparan Sulfate Sulfotransferases</article-title>. <source>ACS Catal.</source> <volume>11</volume>, <fpage>10974</fpage>&#x2013;<lpage>10987</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.1c03088</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girdhar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chemla</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Gruebele</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Better Biomolecule Thermodynamics from Kinetics</article-title>. <source>J. Chem. Phys.</source> <volume>135</volume>, <fpage>015102</fpage>. <pub-id pub-id-type="doi">10.1063/1.3607605</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gnutt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sistemich</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ebbinghaus</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019a</year>). <article-title>Protein Folding Modulation in Cells Subject to Differentiation and Stress</article-title>. <source>Front. Mol. Biosci.</source> <volume>6</volume>, <fpage>38</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2019.00038</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gnutt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Timr</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ahlers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>K&#xf6;nig</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Manderfeld</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Heyden</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019b</year>). <article-title>Stability Effect of Quinary Interactions Reversed by Single Point Mutations</article-title>. <source>J. Am. Chem. Soc.</source> <volume>141</volume>, <fpage>4660</fpage>&#x2013;<lpage>4669</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.8b13025</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grum</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>van den Boom</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Matena</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Link</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>A Heterodimer of Human 3&#x2032;-Phospho-Adenosine-5&#x2032;-Phosphosulphate (PAPS) Synthases Is a New Sulphate Activating Complex</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>395</volume>, <fpage>420</fpage>&#x2013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2010.04.039</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Handa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tham</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Horemuzova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Grigelioniene</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Autosomal Recessive Brachyolmia: Early Radiological Findings</article-title>. <source>Skeletal Radiol.</source> <volume>45</volume>, <fpage>1557</fpage>&#x2013;<lpage>1560</lpage>. <pub-id pub-id-type="doi">10.1007/s00256-016-2458-8</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haque</surname>
<given-names>M. F. u.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Krakow</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Rusiniak</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Swank</surname>
<given-names>R. T.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Mutations in Orthologous Genes in Human Spondyloepimetaphyseal Dysplasia and the Brachymorphic Mouse</article-title>. <source>Nat. Genet.</source> <volume>20</volume>, <fpage>157</fpage>&#x2013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1038/2458</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harjes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bayer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Scheidig</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The Crystal Structure of Human PAPS Synthetase 1 Reveals Asymmetry in Substrate Binding</article-title>. <source>J. Mol. Biol.</source> <volume>347</volume>, <fpage>623</fpage>&#x2013;<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2005.01.005</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iida</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Simsek-Kiper</surname>
<given-names>P. &#xd6;.</given-names>
</name>
<name>
<surname>Mizumoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hoshino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Elcioglu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Horemuzova</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Clinical and Radiographic Features of the Autosomal Recessive Form of Brachyolmia Caused byPAPSS2Mutations</article-title>. <source>Hum. Mutat.</source> <volume>34</volume>, <fpage>1381</fpage>&#x2013;<lpage>1386</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22377</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kabsch</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Dictionary of Protein Secondary Structure: Pattern Recognition of Hydrogen-Bonded and Geometrical Features</article-title>. <source>Biopolymers</source> <volume>22</volume>, <fpage>2577</fpage>&#x2013;<lpage>2637</lpage>. <pub-id pub-id-type="doi">10.1002/bip.360221211</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klassen</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Boles</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Sulfation and Sulfotransferases 5: the Importance of 3&#x2019;-phosphoadenosine 5&#x2019;-phosphosulfate (PAPS) in the Regulation of Sulfation</article-title>. <source>FASEB J.</source> <volume>11</volume>, <fpage>404</fpage>&#x2013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1096/fasebj.11.6.9194521</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Klinge</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Prough</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2018</year>). &#x201c;<article-title>Dehydroepiandrosterone Research: Past, Current, and Future</article-title>,&#x201d; in <source>Vitamins and Hormones</source> (<publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Elsevier</publisher-name>), 108.<fpage>1</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/bs.vh.2018.02.002</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Warman</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Domowicz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krueger</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Deyrup</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>A Member of a Family of Sulfate-Activating Enzymes Causes Murine Brachymorphism</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>95</volume>, <fpage>8681</fpage>&#x2013;<lpage>8685</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.15.8681</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyake</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Elcioglu</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Iida</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Isguven</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>PAPSS2mutations Cause Autosomal Recessive Brachyolmia</article-title>. <source>J. Med. Genet.</source> <volume>49</volume>, <fpage>533</fpage>&#x2013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2012-101039</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Gilligan</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Idkowiak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arlt</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>P. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The Regulation of Steroid Action by Sulfation and Desulfation</article-title>. <source>Endocr. Rev.</source> <volume>36</volume>, <fpage>526</fpage>&#x2013;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1210/er.2015-1036</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Idkowiak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gesteira</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>Vallet</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hardman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van den Boom</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Human DHEA Sulfation Requires Direct Interaction between PAPS Synthase 2 and DHEA Sulfotransferase SULT2A1</article-title>. <source>J. Biol. Chem.</source> <volume>293</volume>, <fpage>9724</fpage>&#x2013;<lpage>9735</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA118.002248</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Shafqat</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Adenosine-5&#x2032;-phosphosulfate - a Multifaceted Modulator of Bifunctional 3&#x2032;-Phospho-Adenosine-5&#x2032;-Phosphosulfate Synthases and Related Enzymes</article-title>. <source>FEBS J.</source> <volume>280</volume>, <fpage>3050</fpage>&#x2013;<lpage>3057</lpage>. <pub-id pub-id-type="doi">10.1111/febs.12252</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noordam</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dhir</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>McNelis</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Schlereth</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hanley</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Krone</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Inactivating PAPSS2 Mutations in a Patient with Premature Pubarche</article-title>. <source>N. Engl. J. Med.</source> <volume>360</volume>, <fpage>2310</fpage>&#x2013;<lpage>2318</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0810489</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oostdijk</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Idkowiak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>House</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>O&#x27;Reilly</surname>
<given-names>M. W.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>PAPSS2 Deficiency Causes Androgen Excess via Impaired DHEA Sulfation-In Vitro and In Vivo Studies in a Family Harboring Two Novel PAPSS2 Mutations</article-title>. <source>J. Clin. Endocrinol. Metab.</source> <volume>100</volume>, <fpage>E672</fpage>&#x2013;<lpage>E680</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2014-3556</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paganini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gramegna Tota</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Superti-Furga</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Skeletal Dysplasias Caused by Sulfation Defects</article-title>. <source>Ijms</source> <volume>21</volume>, <fpage>2710</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21082710</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Garcia</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Whalen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gurtunca</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Novel Inactivating Homozygous PAPSS2 Mutation in Two Siblings with Disproportionate Short Stature</article-title>. <source>AACE Clin. Case Rep.</source>. <pub-id pub-id-type="doi">10.1016/j.aace.2021.11.003</pub-id> <ext-link ext-link-type="uri" xlink:href="https://www.aaceclinicalcasereports.com/article/S2376-0605(21)00121-8/fulltext">https://www.aaceclinicalcasereports.com/article/S2376-0605(21)00121-8/fulltext</ext-link>. </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prydz&#xa0;</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Determinants of Glycosaminoglycan (GAG) Structure</article-title>. <source>Biomolecules</source> <volume>5</volume>, <fpage>2003</fpage>&#x2013;<lpage>2022</lpage>. <pub-id pub-id-type="doi">10.3390/biom5032003</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sasisekharan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sasisekharan</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Structural Insights into Biological Roles of Protein-Glycosaminoglycan Interactions</article-title>. <source>Chem. Biol.</source> <volume>12</volume>, <fpage>267</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2004.11.020</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Poirier</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Protein Aggregation and Neurodegenerative Disease</article-title>. <source>Nat. Med.</source> <volume>10</volume>, <fpage>S10</fpage>&#x2013;<lpage>S17</lpage>. <pub-id pub-id-type="doi">10.1038/nm1066</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schr&#xf6;der</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gebel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Eremeev</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Morgner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grum</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Knauer</surname>
<given-names>S. K.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Human PAPS Synthase Isoforms Are Dynamically Regulated Enzymes with Access to Nucleus and Cytoplasm</article-title>. <source>PLoS ONE</source> <volume>7</volume>, <fpage>e29559</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0029559</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekulic</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dietrich</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Paarmann</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ort</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Konrad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lavie</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Elucidation of the Active Conformation of the APS-Kinase Domain of Human PAPS Synthetase 1</article-title>. <source>J. Mol. Biol.</source> <volume>367</volume>, <fpage>488</fpage>&#x2013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2007.01.025</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soto</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pritzkow</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Protein Misfolding, Aggregation, and Conformational Strains in Neurodegenerative Diseases</article-title>. <source>Nat. Neurosci.</source> <volume>21</volume>, <fpage>1332</fpage>&#x2013;<lpage>1340</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0235-9</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strott</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Sulfonation and Molecular Action</article-title>. <source>Endocr. Rev.</source> <volume>23</volume>, <fpage>703</fpage>&#x2013;<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1210/er.2001-0040</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>T&#xfc;ys&#xfc;z</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Y&#x131;lmaz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>G&#xfc;l</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kolb</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bilguvar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Evliyao&#x11f;lu</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Spondyloepimetaphyseal Dysplasia Pakistani Type: Expansion of the Phenotype</article-title>. <source>Am. J. Med. Genet.</source> <volume>161</volume>, <fpage>1300</fpage>&#x2013;<lpage>1308</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35906</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Boom</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Heider</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>3&#x2032;-Phosphoadenosine 5&#x2032;-Phosphosulfate (PAPS) Synthases, Naturally Fragile Enzymes Specifically Stabilized by Nucleotide Binding</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume>, <fpage>17645</fpage>&#x2013;<lpage>17655</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.325498</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>V&#xf6;pel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bravo-Rodriguez</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mittal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vachharajani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gnutt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Inhibition of Huntingtin Exon-1 Aggregation by the Molecular Tweezer CLR01</article-title>. <source>J. Am. Chem. Soc.</source> <volume>139</volume>, <fpage>5640</fpage>&#x2013;<lpage>5643</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.6b11039</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>V&#xf6;pel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Davico</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gro&#xdf;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>B&#xfc;ning</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kareth</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Infrared Laser Triggered Release of Bioactive Compounds from Single Hard Shell Microcapsules</article-title>. <source>Chem. Commun.</source> <volume>51</volume>, <fpage>6913</fpage>&#x2013;<lpage>6916</lpage>. <pub-id pub-id-type="doi">10.1039/C4CC09745A</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Protein Aggregation and its Inhibition in Biopharmaceutics</article-title>. <source>Int. J. Pharmaceutics</source> <volume>289</volume>, <fpage>1</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2004.11.014</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waters</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Degradation of Mutant Proteins, Underlying &#x201c;Loss of Function&#x201d; Phenotypes, Plays a Major Role in Genetic Disease</article-title>. <source>Curr. Issues Mol. Biol.</source> <volume>3</volume> (<issue>3</issue>), <fpage>57</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.21775/cimb.003.057</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winklhofer</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Tatzelt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Haass</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The Two Faces of Protein Misfolding: Gain- and Loss-Of-Function in Neurodegenerative Diseases</article-title>. <source>EMBO J.</source> <volume>27</volume>, <fpage>336</fpage>&#x2013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601930</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>